1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Personalized Medicine Market Analysis

Personalized Medicine Market Analysis

  • May 2013
  • -
  • RNCOS
  • -
  • 90 pages

Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as per individuals. The growing research applications and identification of molecular markers towards disease predisposition and progression have led to the growth of personalized medicine. Industry players have also rapidly adopted this field and are progressing towards achieving higher goals in the same.

According to our new research report, “Personalized Medicine Market Analysis”, the U.S. represents the brightest market for personalized medicine and is anticipated to grow at a CAGR of around 9.5% during 2012-2017. The need for rapid detection of diseases, especially cancer,and their more efficient treatments are primarily driving this market.

Besides USA, countries like the U.K., France, Germany, India, China, and Japan have also been trying to pioneer personalized medicine with the help of advanced technologies. A lot of investment has been undergoing for research and development to develop biomarkers and personalized healthcare solutions in order to improve the medical outcomes. Our report provides a prudent analysis at the country level, elucidating the level of personalized medicine penetration, recent industry developments and the future growth prospects.

Companies are actively involved in the development of advanced technological tools and diagnostic equipments that help in promoting personalized medicine. Strategic alliances and consolidation has also become a common trend towards greater market presence. Academic and private research institutions as well as small biotech and major pharmaceutical companies are increasingly looking for alternative ways to strengthen their pipelines. The report highlights the various strategies being adopted by market players and research institutes to promote growth in this field.

The report also covers the industry positioning in terms of the major therapeutic areas. The study also provides an insight into the segment-wise competitive landscape, which includes the profiles of Pharmaceutical/Biotech, Diagnostic, IT/Informatics, and Research Tool companies across the globe. Through the report, companies planning to venture into the personalized medicine sector will also have an in-depth understanding of the industry dynamics.

Table Of Contents

Personalized Medicine Market Analysis
1. Analyst View
2. Research Methodology
3. Personalized Medicine Market: An Introduction
4. Personalized Medicine Market
4.1 Therapeutics
4.1.1 Cancer
4.1.2 Cardiovascular Diseases
4.1.3 Neurological Disorders
4.2 Diagnostics
5. Market Participants
5.1 Pharmaceutical Companies
5.2 Diagnostic Companies
5.3 Technology Providers
5.4 Healthcare Providers
5.5 Insurance Companies
6. Key Geographical Markets
6.1 US
6.2 Europe
6.3 Emerging Markets
6.3.1 Japan
6.3.2 China
6.3.3 India
7. Market Drivers and Restraints
7.1 Drivers
7.1.1 Increasing Focus of Personalized Medicine in Cancer
7.1.2 Robust Advancements in Pharmacogenomics and Pharmacogenetics
7.1.3 Personalization for Prevention of ADR's
7.1.4 Healthcare Costs Savings
7.2 Restraints
7.2.1 Reimbursement
7.2.2 Privacy, Confidentiality and Patients' Rights
8. Regulatory Environment
9. Competitive Landscape
9.1 Pharma/Biotech Companies
9.1.1 Abbott Laboratories
9.1.2 Genzyme Corporation
9.1.3 Novartis AG
9.1.4 Bristol-Myers Squibb Company
9.2 IT/Informatics Companies
9.2.1 IBM
9.2.2 Oracle Health Sciences
9.2.3 XIFIN, Inc.
9.2.4 CTIS, Inc.
9.3 Diagnostic Companies
9.3.1 Siemens
9.3.2 Roche
9.3.3 Rosetta Genomics Ltd.
9.3.4 QIAGEN N.V.
9.3.5 Gen-Probe Incorporated
9.3.6 Dako Denmark A/S
9.3.7 BioMerieux SA
9.4 Research Tool Companies
9.4.1 Affymetrix, Inc.
9.4.2 DNA Genotek
9.4.3 Illumina, Inc.
9.4.4 Life Technologies Corporation
9.4.5 Pacific Biosciences

List of Figures:

Figure 6-1: US - Personalized Medicine Market (Billion US$), 2012-2017
Figure 6-2: US - Personalized Medicine Market by Segment (%), 2012

List of Tables:

Table 4-1: Personalized Medicine for Cancer by Therapy (2011)
Table 4-2: Personalized Medicine for Cardiovascular Diseases by Therapy (2011)
Table 4-3: Personalized Medicine for Neurological Disorders by Therapy (2011)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Asthma Therapeutics in Asia-Pacific Markets to 2021 - High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns

Asthma Therapeutics in Asia-Pacific Markets to 2021 - High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns

  • $ 4 995
  • Industry report
  • March 2016
  • by GBI Research

Asthma Therapeutics in Asia-Pacific Markets to 2021 - High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns Summary Asthma is a common chronic inflammatory ...

Continuous Renal Replacement Therapy (CRRT) - Global Market Outlook (2015-2022)

Continuous Renal Replacement Therapy (CRRT) - Global Market Outlook (2015-2022)

  • $ 4 157
  • Industry report
  • March 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Continuous Renal Replacement Therapy (CRRT) Market is accounted for $0.78 billion in 2015 and is expected to reach $1.26 billion by 2022 growing at a CAGR of 7.1%. ...

Therapy Markets in China

Therapy Markets in China

  • $ 4 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

China's demand for Therapy has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which ...

Therapy Companies In China

March 2016 $ 1 800

Download Unlimited Documents from Trusted Public Sources

Therapy Industry in the US

  • April 2016
    148 pages
  • Hospital  

    Medical  

    Cancer  

  • United States  

View report >

Therapy Demand Analysis

  • April 2016
    14 pages
  • Therapy  

View report >

Pathology Description in the US

  • April 2016
    40 pages
  • Cancer  

    Oncology  

    Hospital  

  • United States  

View report >

Related Market Segments :

Therapy
Cancer
Pharmaceutical
Oncology
Neurology

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.